Abstract
Background
Existing research provides conflicting evidence regarding the relationship between estimated branched-chain amino acid (BCAA) intake and metabolic, glycemic markers, and anthropometric characteristics. This research seeks to examine the association between estimated dietary BCAA consumption and glycemic, and metabolic markers, as well as anthropometric parameters in adults classified as overweight or obese.
Methods
In this cross-sectional analysis, we gathered data from 465 overweight and obese individuals aged between 18 and 37 years. To evaluate dietary data, we employed the food frequency questionnaire, and the BCAA content in foods was determined via the United States Department of Agriculture website. We utilized ELISA kits to measure fasting blood glucose (FBS) and lipid profile markers, and additionally calculated low-density lipoprotein (LDL) and insulin sensitivity markers. We assessed sociodemographic status, physical activity (PA), and anthropometric attributes through a method recognized as both valid and reliable. For statistical analysis, we conducted analyses of covariance (ANCOVA), making adjustments for variables including sex, PA, age, energy, and body mass index (BMI).
Results
Upon adjusting for confounders, those in the highest tertiles of BCAA intake exhibited an increase in weight, BMI, waist circumference (WC), waist-to-hip ratio (WHR), and fat-free mass (FFM). Conversely, they demonstrated reduced fat mass (FM) (%) and FM (kg) compared to their counterparts in the lowest tertiles (P < 0.05). Additionally, there was a noted association between greater estimated BCAA intake and reduced LDL levels. Nonetheless, our findings did not reveal a significant relationship between dietary BCAA and glycemic indices.
Conclusions
From our findings, an increased estimated intake of BCAA seems to correlate with diminished serum LDL concentrations. To gain a more comprehensive understanding of this association, it is imperative that further experimental and longitudinal studies be conducted.
Keywords: BCAA, Metabolic and glycemic markers, Anthropometric measurements, LDL
Background
In the past few decades, metabolic diseases have emerged as some of the most significant public health problems worldwide. Obesity, fatty liver, and diabetes are now among the most prevalent metabolic diseases across all age groups. The obesity epidemic has been recognized by the World Health Organization (WHO) as one of the top 10 global health problems [1–5]. Obesity has reached epidemic proportions in many countries around the world and is closely associated with several chronic diseases, including metabolic disease. Branched-chain amino acids (BCAAs) are essential amino acids with nonlinear aliphatic side chains, including isoleucine, leucine, and valine [6, 7]. A diet rich in BCAAs has been associated with metabolic health, including body weight regulation, muscle protein synthesis, and glucose and lipid homeostasis [8–10]. However, some other studies show different results; according to new research, reducing the amount of BCAAs in the diet may reverse the trend of diet-induced obesity [11–15].
Studies indicate that lifestyle modifications, such as weight loss, increased physical activity (PA), and dietary changes, can enhance glucose tolerance and improve lipid profiles [16–23]. In general, BCAA plays several important metabolic and physiological roles, beyond being considered substrates for the synthesis of proteins [24]. Reports show that BCAA serves as signaling molecules that regulate the metabolism of glucose, lipid, and protein [24]. An increase in the plasma level of BCAA is likely associated with insulin sensitivity [25]. In a study conducted on women (mean age = 54.9 years, SD = 7.2 years), there was an inverse relationship between increased serum levels of BCAAs and lipid abnormalities [26]. Yet, prior studies investigating the relationship between BCAA and genetics concerning diabetes and insulin resistance have shown conflicting results [27–30]. Also, it remains debatable whether the dietary intake of these amino acids is associated with insulin resistance and dyslipidemia [25, 26].
The nutritional status of adults is assessed through several methods, with anthropometric measurements being the most well-known [31, 32]. Obesity leads to changes in body composition, which in turn affect energy expenditure, diet, fat-free mass, and fat mass [33–35]. In mice, an increased intake of protein and BCAAs has been linked to both elevated circulating BCAA levels and changes in body composition [36–39]. However, no study to date has examined the correlation between the estimated intake of BCAA and both metabolic and glycemic markers and anthropometric indicators in overweight and obese adults.
Methods
Participant population
This cross-sectional study comprised 465 overweight and obese individuals from Tabriz, Iran. Furthermore, the study only included subjects who were in good general health. The participants were selected from three recent projects conducted at the Tabriz University of Medical Sciences [40–42]. The study flowchart is illustrated in (Fig. 1). HOMA-IR was used to calculate sample size [43] z = 1.96, σ = 4.41, δ = 0.27; Using the formula: n=
; the total sample count reached 465, accounting for 10% missing data. The sample size was determined with α = 0.05 and β = 0.2, yielding power of 80%. For categorization, given the 80% power, dividing the data into tertiles was deemed the optimal approach, both to avoid false positives from multiple comparisons and false negatives due to insufficient power [44, 45].
Fig. 1.
Study flowchart
Inclusion criteria included: consent to participate in the study, a BMI greater than 25 kg/
, and age between 18 and 37 years. Exclusion criteria included: a history of hypertension, PCOS, CVD, diabetes mellitus or prediabetes, impaired liver or renal function, bariatric surgery, regular use of medications such as oral contraceptive pills, weight-altering medications, BCAA, and high-protein supplements, smoking, alcohol and drug use, pregnancy, currently breastfeeding, and menopause. All participants completed and signed a written informed consent form. The ethics committee of the Tabriz College of Medical Sciences approved the study proposal (Code: IR.TBZMED.REC.1398.460).
Dietary BCAAs calculation
Dietary intake was assessed using a 168-item food frequency questionnaire (FFQ) [46, 47]. The Nutritionist 4 software (version 7.0; N Squared Computing, Salem, OR) was employed to calculate calories and nutrients in the Iranian diet. The USDA database was applied to determine the BCAAs content of each food product. By entering the name of each product into the USDA website [48], the amount of BCAAs per 100 g of each food was calculated, divided by 100, and then multiplied by the gram of the same food. Finally, the total amount of all BCAAs in the different foods was added to obtain the total amount of BCAAs.
Sociodemographic, anthropometric, and physical activity measurements
A nutritionist recorded socio-demographic data, including age, sex, and education level, as well as anthropometric measures like body mass index (BMI), height, weight, waist circumference (WC), hip circumference (HC), and waist-to-hip ratio (WHR). A Seca 753E electronic scale was used to measure the weight of the subjects with minimal deviation (accurate to 0.1 kg). The BMI of the subjects was determined using the formula (kg/
, and their standing height was measured (to the nearest 0.1 cm) without shoes. The WHR was derived by dividing the WC by the maximum HC for each participant. After 8 h of fasting, the body composition of participants was assessed using a bioelectrical impedance analysis (BIA) device (Tanita, BC-418 MA, Tokyo, Japan) while they were dressed in light clothing. Though two to three hours of fasting is typically sufficient to measure body composition, participants in this study were not restricted from drinking water. Other criteria for body composition measurement that we adhered to in our study included: no smoking, alcohol, or caffeine intake, no consumption of certain spices such as black pepper, mustard, paprika, and red hot chili peppers 24 h before measurement, refraining from exercise 4 to 6 h prior to measurement, no jewelry or cell phone use during the body composition analysis, wearing no heavy clothing, and avoiding food and water consumption at least 2 h before measurement [49]. The short form of the International Physical Activity Questionnaire (IPAQ), which consists of seven simple questions, was used to assess the level of PA. Its validity and reliability have been previously established [50].
Biochemical measurements
All participants underwent a blood draw from the brachial vein after an 8-hour fasting period. Serum samples were stored for laboratory analysis by being frozen at -86 °C. Fasting blood glucose (FBS), fasting insulin (FI), total cholesterol (TC), triglycerides (TG), and high-density lipoprotein (HDL) were determined using an ELISA (enzyme-linked immunosorbent assay) kit, following the manufacturer’s instructions. The low-density lipoprotein (LDL) concentration was determined using the Friedewald Eq. (51). The homeostatic model of insulin resistance (HOMA-IR) was assessed using the formula fasting insulin (µIU/mL) × fasting blood glucose (mmol/L)/22.5, and quantitative insulin sensitivity index (QUICKI) as 1/[log fasting insulin (mU/L) + log (fasting plasma glucose (mmol/L) ×18.0182)] [52, 53].
Statistical analysis
The data gathered were analyzed using SPSS software (version 21.0; SPSS Inc, Chicago, IL). A P-value of less than 0.05 was considered significant. Qualitative data were represented as numbers and percentages (%), while quantitative data were expressed as mean and standard deviation (SD). The Shapiro-Wilk test (p > 0.05) was used to confirm normality, and Levene’s test (p > 0.05) verified the equality of error variances. Bonferroni’s post hoc multiple comparison analysis indicated significant mean differences between groups. To compare the biochemical and anthropometric variables, we used analysis of covariance (ANCOVA), the general linear model (GLM), and univariate analysis, with adjustments for confounding factors such as age, sex, BMI, PA, and energy intake.
Results
A total of 527 men and women, aged between 18 and 37 years, participated in this study, with 465 subjects completing the measurements. Table 1 presents the general characteristics, anthropometric data, and body composition measurements of the participants across the tertiles of BCAA. A significant difference was observed in weight, height, BMI, WC, HC, WHR, FM, and FFM across the BCAA categories. Furthermore, after adjustments for age, sex, calorie intake, and physical activity, participants in the highest tertiles of BCAA presented higher weight (P = 0.005), BMI (P = 0.007), WC (P = 0.002), WHR (P = 0.017), FFM (%) (P = 0.041), and FFM (kg) (P = 0.035) compared to those in the lowest tertiles. Conversely, after adjusting for age, sex, calorie intake, and physical activity, subjects in the lowest tertiles of BCAA exhibited higher FM (%) (P = 0.005) and FM (kg) (P = 0.038) compared to those in the highest.
Table 1.
General characteristics and anthropometric measurements of study participants across different tertiles of dietary intake of BCAA
| Variables | BCAA | ||||
|---|---|---|---|---|---|
| T1 (n = 155) (6.99–16.32) |
T2 (n = 155) (16.35–23.77) |
T3 (n = 155) (23.87–93.87) |
*P | **P | |
| Age (year) | 35.67(11.76) | 36.74(10.75) | 36.61(10.96) | 0.652 | 0.824 |
| Gender (male %) | 62(40.0) | 94(61.0) | 108(69.2) | 0.000 | - |
| Marital status (single %) | 116(74.8) | 89(57.8) | 102(65.4) | 0.080 | - |
| Education (university graduate %) | 52(33.5) | 50(32.5) | 58(37.2) | 0.500 | - |
| Occupation status (student %) | 112(72.3) | 114(74.0) | 122(78.2) | 0.227 | - |
| Weight (kg) | 80.25(17.63) | 89.61(17.21) | 89.25(15.61) | 0.000 | 0.005† |
| Height (cm) | 166.57(9.28) | 169.61(10.27) | 170.84(9.75) | 0.000 | 0.952 |
| BMI (kg/m2) | 28.97(6.18) | 31.20(6.04) | 30.69(5.56) | 0.003 | 0.007† |
| WC (cm) | 94.55(15.71) | 102.39(15.08) | 101.36(15.09) | 0.000 | 0.002† |
| HC (cm) | 109.66(10.81) | 112.68(11.74) | 111.41(9.91) | 0.050 | 0.076 |
| WHR (cm) | 0.85(0.09) | 0.90(0.09) | 0.90(0.09) | 0.000 | 0.017† |
| FM (%) | 37.49(14.84) | 35.65(13.12) | 32.19(11.88) | 0.002 | 0.005‡‡ |
| FM (kg) | 30.66(13.73) | 32.04(12.28) | 29.00(11.43) | 0.102 | 0.038‡‡ |
| FFM (%) | 69.32(15.39) | 66.30(12.43) | 69.39(12.03) | 0.069 | 0.041 |
| FFM (kg) | 54.09(10.80) | 58.37(12.01) | 61.22(12.14) | 0.000 | 0.035‡ |
| PA (met-hour/week) | 3.08(2.90) | 3.11(4.26) | 3.85(5.99) | 0.238 | 0.656 |
BMI: body mass index; WC: waist circumference; HC: hip circumference; WHR: waist-to-hip ratio; FM: fat mass; FFM: fat free mass; PA: physical activity. Data are presented as mean ± SD or percent; *Obtained from the one-way analysis of variance (ANOVA) or Chi-squared tests, where appropriate; P Significant at P < 0.05; 95th confidence intervals of the difference in parentheses **Obtained from ANCOVA model after adjustment for the confounding effects of age, sex, calorie intake and physical activity; P Significant at P < 0.05; 95th confidence intervals of the difference in parentheses
† post hoc Tukey signature difference between 1st tertile and 2nd tertile
‡ post hoc Tukey signature difference between 1st tertile and 3rd tertile
‡‡ post hoc Tukey signature difference between 2nd tertile and 3rd tertile
Table 2 presents the estimated intake of BCAA for participants across the tertiles of BCAA. An upward trend was observed in energy, protein, CHO, cholesterol, zinc, phosphorus, calcium, manganese, fluoride, vitamin C, vitamin B1, vitamin B2, vitamin B3, vitamin B9, vitamin B12, and vitamin D across BCAA tertiles (from T1 to T3). This trend was evident in both the crude analysis and after adjustments for age, sex, BMI, physical activity, and calorie intake (P ≤ 0.05).
Table 2.
Energy adjusted dietary intakes of study participants across different tertiles of dietary intake of BCAA
| Variables | BCAA | ||||
|---|---|---|---|---|---|
| T1 (n = 155) (6.99–16.32) |
T2 (n = 155) (16.35–23.77) |
T3 (n = 155) (23.87–93.87) |
*P | **P | |
| Energy (kcal) | 2107.56(639.66) | 2886.33(830.09) | 3729.59(1212.15) | 0 < 0.001 | 0 < 0.001†‡a |
| Branched Chains Amino Acids (gr/day) | 12.95(2.13) | 19.93(2.26) | 33.63(11.35) | 0 < 0.001 | 0 < 0.001†‡a |
| Protein (g/day) | 68.23(18.60) | 92.69(21.84) | 132.63(49.51) | 0 < 0.001 | 0 < 0.001‡a |
| Fat (g/day) | 69.26(25.45) | 95.24(40.91) | 127.54 (57.98) | 0 < 0.001 | 0.540 |
| CHO (g/day) | 320.29(119.31) | 437.22(137.50) | 536.03(181.35) | 0 < 0.001 | 0.006a |
| Total Fiber (g/day) | 34.08(21.04) | 54.28(29.91) | 71.62(51.33) | 0 < 0.001 | 0.499 |
| SFA (g/day) | 20.66(8.15) | 27.75(12.32) | 38.49(21.93) | 0 < 0.001 | 0.476 |
| MUFA (g/day) | 22.41(8.78) | 31.41(15.30) | 42.14(20.51) | 0 < 0.001 | 0.834 |
| PUFA(g/day) | 15.63(6.70) | 22.08(13.67) | 27.74(15.05) | 0 < 0.001 | 0.609 |
| Cholesterol (mg/day) | 179.38(103.18) | 263.13(217.67) | 394.90(231.99) | 0 < 0.001 | 0 < 0.001‡a |
| Sodium (mg/day) | 3152.19(1384.36) | 4362.41(2161.64) | 5289.44(2507.03) | 0 < 0.001 | 0.171 |
| Iron (mg/day) | 17.28(6.17) | 23.92(13.53) | 29.73(11.31) | 0 < 0.001 | 0.195 |
| Magnesium (mg/day) | 345.25(137.22) | 479.16(145.96) | 636.23(285.89) | 0 < 0.001 | 0.071 |
| Zinc (mg/day) | 9.49(3.38) | 12.89(4.03) | 18.28(8.81) | 0 < 0.001 | 0.006a |
| Phosphorus (mg/day) | 1206.98(387.55) | 1657.10(501.58) | 2197.03(792.94) | 0 < 0.001 | 0 < 0.001‡a |
| Calcium (mg/day) | 910.68(305.89) | 1234.33(410.10) | 1636.01(700.41) | 0 < 0.001 | 0.004‡a |
| Potassium (mg/day) | 3335.10(1566.32) | 4451.69(1600.62) | 5608.71(2248.20) | 0 < 0.001 | 0.904 |
| Copper (mg/day) | 1.97(0.70) | 2.51(0.93) | 3.48(2.00) | 0 < 0.001 | 0.321 |
| Manganese (mg/day) | 4.95(2.36) | 7.54(2.88) | 10.26(4.76) | 0 < 0.001 | 0 < 0.001†‡a |
| Selenium (mg/day) | 75.52(63.93) | 116.21(71.39) | 146.27(99.50) | 0 < 0.001 | 0.218 |
| Fluoride (mg/day) | 3029.03(3542.05) | 4108.20(3895.14) | 7788.42(7265.19) | 0 < 0.001 | 0 < 0.001†‡a |
| Chromium (mg/day) | 0.09(0.07) | 0.14(0.09) | 0.16(0.13) | 0 < 0.001 | 0.293 |
| Vitamin C (mg/day) | 190.25(168.13) | 230.10(175.24) | 235.91(166.03) | 0.037 | 0 < 0.001‡a |
| VitaminB1 (mg/day) | 1.72(0.56) | 2.43(0.73) | 3.19(1.21) | 0 < 0.001 | 0.008 |
| VitaminB2 (mg/day) | 1.63(0.58) | 2.31(0.74) | 3.21(1.31) | 0 < 0.001 | 0 < 0.001 |
| VitaminB3 (mg/day) | 19.77(6.05) | 27.71(7.15) | 37.28(13.52) | 0 < 0.001 | 0 < 0.001 |
| VitaminB6 (mg/day) | 1.54(0.66) | 2.16(0.88) | 2.63(1.03) | 0 < 0.001 | 0.399 |
| VitaminB9 (µg/day) | 419.86(205.97) | 610.22(231.46) | 803.51(378.49) | 0 < 0.001 | 0.015‡a |
| VitaminB12 (µg/day) | 3.54(1.97) | 4.86(2.97) | 9.61(15.06) | 0 < 0.001 | 0.078 |
| VitaminB5 (mg/day) | 5.15(1.80) | 6.66(2.43) | 8.44(3.34) | 0 < 0.001 | 0.926 |
| VitaminB8 (mg/day) | 27.44(15.45) | 36.83(15.60) | 44.34(21.17) | 0 < 0.001 | 0.852 |
| Vitamin A (RAE/day) | 735.05(448.10) | 945.26(629.34) | 1422.96(1480.44) | 0 < 0.001 | 0.491 |
| Vitamin D (µg/day) | 1.52(1.07) | 2.03(1.48) | 2.62(2.22) | 0 < 0.001 | 0.003‡ |
| Vitamin K (µg/day) | 180.17(136.27) | 223.39(147.38) | 327.92(292.63) | 0 < 0.001 | 0.071 |
| Vitamin E (mg/day) | 9.02(6.34) | 13.90(9.47) | 15.45(9.53) | 0 < 0.001 | 0.198 |
CHO: Carbohydrate; SFA: Saturated fatty acids; MUFA: Monounsaturated fatty acids; PUFA: Polyunsaturated fatty acids *P Significant at P < 0.05; 95th confidence intervals of the difference in parentheses. **P values are obtained from ANCOVA model after adjustment for the confounding effects of age, sex, BMI and physical activity, calorie intake
† post hoc Tukey signature difference between 1st tertile and 2nd tertile
‡ post hoc Tukey signature difference between 1st tertile and 3rd tertile
a: post hoc Tukey signature difference between 2nd tertile and 3rd tertile
Table 3 displays the distribution of food groups across the tertiles of BCAA. Significant differences emerged in the consumption of fruits, vegetables, MFP (Meat, Fish, Poultry), dairy, grains, nuts, beans, and fiber across the BCAA tertiles. Furthermore, in the adjusted model, the tertiles of BCAA showed a statistically significant association with fruits, MFP, dairy, and grains.
Table 3.
Consumption rates of 8 diet components (grams/day)
| Variables | BCAA | ||||
|---|---|---|---|---|---|
| T1 (n = 155) (6.99–16.32) |
T2 (n = 155) (16.35–23.77) |
T3 (n = 155) (23.87–93.87) |
*P | **P | |
| Fruits (g/d) | 509.77(502.51) | 654.96(579.24) | 622.02(542.65) | 0.048 | 0 < 0.001† |
| Vegetables (g/d) | 272.45(191.68) | 325.53(185.47) | 396.94(316.18) | 0 < 0.001 | 0.960 |
| MFP (g/d) | 57.09 (31.70) | 73.34(40.51) | 127.51(132.40) | 0 < 0.001 | 0 < 0.001†† |
| Dairy (g/d) | 253.13(170.32) | 330.23(240.01) | 462.28(394.62) | 0 < 0.001 | 0.009†† |
| Grains (g/d) | 409.36(155.69) | 563.23(206.41) | 731.59(289.61) | 0 < 0.001 | 0 < 0.001†† |
| Nuts(g/day) | 11.52(15.37) | 20.10(28.85) | 44.68(120.08) | 0 < 0.001 | 0.269 |
| Beans(g/day) | 33.41(25.35) | 47.48(39.21) | 66.95(73.48) | 0 < 0.001 | 0.339 |
| Fiber (g/day) | 13.63(10.22) | 18.49(11.08) | 22.62(19.03) | 0 < 0.001 | 0.10 |
MFP; meat, Fish, Poultry. All data are expressed as mean (± SD). P-values derived from one-way ANOVA. *All variables were adjusted for demographic characteristics including age, sex, physical activity and calorie intake. The bold values represent statistically significance
† post hoc Tukey signature difference between 1st tertile and 2nd tertile
‡ post hoc Tukey signature difference between 1st tertile and 3rd tertile
†† post hoc Tukey signature difference between 2nd tertile and 3rd tertile
Table 4 outlines the association between the estimated intake of BCAA and biochemical parameters in both crude and adjusted models. A one-way ANOVA analysis examining the relationship between the BCAA tertiles and biochemical parameters indicated that an increased estimated intake of BCAA correlates with reductions in TC (P = 0.008) and LDL (P = 0.002). Even after adjustments for age, sex, BMI, physical activity, and calorie intake, this relationship remained statistically significant for LDL (P = 0.02).
Table 4.
Biochemical parameters of study participants across different tertiles of dietary intake of BCAA
| Variables | BCAA | ||||
|---|---|---|---|---|---|
| T1 (n = 155) (6.99–16.32) |
T2 (n = 155) (16.35–23.77) |
T3 (n = 155) (23.87–93.87) |
*P | **P | |
| FBS (mg/dl) | 84.13(14.47) | 87.37(16.81) | 88.35(24.21) | 0.123 | 0.453 |
| Insulin (µ IU/ml) | 14.54(14.55) | 15.51(18.50) | 14.20(14.44) | 0.754 | 0.758 |
| TC (mg/dl) | 201.06(47.92) | 191.48(38.75) | 186.32(40.12) | 0.008 | 0.117 |
| HDL (mg/dl) | 45.09(10.65) | 45.58(9.84) | 43.90(10.49) | 0.339 | 0.462 |
| LDL (mg/dl) | 132.22(47.88) | 121.92(34.71) | 116.37(37.67) | 0.002 | 0.027‡ |
| TG (mg/dl) | 141.00(96.36) | 148.97(91.98) | 146.65(78.52) | 0.722 | 0.590 |
| HOMA-IR | 3.18(3.42) | 3.39(3.98) | 3.18(3.34) | 0.833 | 0.844 |
| QUICKI | 0.34(0.04) | 0.33(0.03) | 0.33(0.03) | 0.747 | 0.766 |
FBS: fasting blood sugar; TC: total cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TG: triglycerides. *P Significant at P < 0.05; 95th confidence intervals of the difference in parentheses. **P values are obtained from ANCOVA model after adjustment for the confounding effects of age, sex, BMI and physical activity, calorie intake and further adjusted for protein intake for Insulin level
† post hoc Tukey signature difference between 1st tertile and 2nd tertile
‡ post hoc Tukey signature difference between 1st tertile and 3rd tertile
†† post hoc Tukey signature difference between 2nd tertile and 3rd tertile
Discussion
This cross-sectional study explored possible associations between the estimated intake of BCAA and glycemic, metabolic indices, and anthropometric measurements in overweight and obese adults in Iran. The findings from this study suggest that an elevated dietary intake of BCAA associates with an increase in weight, BMI, WC, WHR, and FFM (P < 0.05). Conversely, participants in the highest tertiles of BCAA exhibited lower FM (kg), FM (%), and LDL when compared to subjects in the lowest tertiles (p < 0.05). We observed no significant association between BCAA and glycemic indices (P > 0.05).
Approximately 80% of serum BCAA levels are determined by the consumption of proteins or BCAAs from food or supplements, while the remaining 20% is influenced by their catabolic metabolites [54, 55]. Our findings align with some of the studies’ results regarding the relationship between serum BCAA concentrations and glycemic, metabolic indices, and anthropometric measurements [8, 13, 14, 25, 39, 56, 57]. Several studies have produced mixed findings on the relationship between increased dietary BCAA and glycemic, metabolic, and anthropometric indices. While some research indicates an association with improvements in these indices [58, 59], others suggest the contrary [14, 43, 57, 60].
To the best of our knowledge, no study has explored the relationship between dietary BCAA intake and glycemic, metabolic factors, and anthropometric measurements within the overweight and obese Iranian population. In our research, while glycemic markers trended upward with increased estimated intake of BCAAs, this correlation wasn’t statistically significant. It’s also noteworthy that findings from similar studies offer conflicting results [28, 61]. Zheng et al. observed that an increase in dietary BCAAs corresponded to a 13% elevated risk of diabetes [61]. Another study found that in a Japanese community, a higher estimated intake of BCAA correlated with a reduced risk of diabetes [28]. Several reasons can explain the observed contradictions: (1) Different populations and countries have varying primary dietary sources that contribute to the total BCAA intake. (2) There may be biases in completing the food frequency questionnaire. (3) Various confounding factors are at play. (4) The methodologies for evaluating results differ, such as comparing insulin resistance versus diabetes. Various studies have suggested that an increased dietary intake of BCAA may enhance glucose metabolism, likely through the stimulation of insulin secretion and activation of cell signaling pathways like mTOR (mechanistic Target of Rapamycin) and AMPK (AMP-activated Protein Kinase) [62, 63]. However, the impact of branched-chain amino acid consumption on fasting glucose and insulin levels may be influenced by other factors, including total caloric intake, other dietary components, physical activity, and individual genetics [28, 29, 64]. One possible explanation for this inconsistency might be the interplay between nutritional intake and genetics. Illustratively, a study by Wang et al. posited that dietary BCAAs could amplify the genetic predisposition to an increased risk of type 2 diabetes (T2D) and elevated fasting glucose levels. They further identified that a higher BCAA intake correlated positively with T2D risk in individuals with a high genetic predisposition. Conversely, this association was negative for those with a low genetic predisposition, implying that BCAAs’ influence on T2D risk might be contingent upon an individual’s genetic makeup [27]. Another study indicated that a high consumption of BCAAs correlates with an elevated risk of type 2 diabetes [28, 29].Further research is required to comprehensively understand this beneficial mechanism.
In our investigation, we found that increasing dietary BCAA intake significantly reduced serum LDL levels. However, we didn’t observe a notable correlation between BCAA and total cholesterol, HDL, or TG. Zhang et al. documented that a higher BCAA consumption corresponded to decreased serum cholesterol levels, aligning partially with our findings [29]. Various studies have demonstrated that BCAA can enhance the lipid profile through the activation of the mTOR pathway, increased insulin secretion, and augmented fat metabolism [55, 62, 65]. Conversely, Yang et al.‘s research indicated that a higher intake of BCAA correlated with dyslipidemia [66]. However, to fully comprehend the mechanism behind the dietary intake of BCAA and its association with the lipid profile, further studies are required.
Although in the present study, an increase in dietary BCAAs associated with a rise in weight, BMI, WC, WHR, and FFM. Conversely, the higher tertiles of dietary BCAA were associated with decreases in FM and FM%. It’s worth noting that adipose tissue and the liver might be the primary sites where BCAAs interact with lipid metabolism [67, 68]. In the research by Ribeiro et al., as well as in our own study, an increase in BCAA intake led to weight gain in older mice and males. However, this gain was primarily attributed to a rise in FFM [69]. Conversely, BCAA metabolism also plays a pivotal role in adipocyte differentiation and lipogenesis [70]. There was a positive correlation between plasma BCAA concentrations and markers of visceral adipose tissue (VAT) as well as insulin resistance [71]. The influence of dietary intake of BCAA on body composition varies based on the amount of these amino acids consumed and other dietary components. Increasing the intake of BCAA can stimulate protein synthesis through enhanced insulin secretion, which influences the fat-free mass. Conversely, by boosting fat metabolism, it can also impact the fat mass [33, 62].
Obesity impedes BCAA catabolism by downregulating the expression of genes linked to the branched-chain alpha-keto acid dehydrogenase complex (BCKD) [71]. The expression level of BCKD mRNA in VAT is diminished in obese women with metabolic syndrome compared to obese women without glucose metabolism issues [72]. Levels of BCAAs and their intermediates, including C3- and C5-acylcarnitine, were elevated in obese individuals [73]. There’s a need for another longitudinal study to bridge this knowledge gap. In our analysis, while we considered factors like age, sex, BMI, PA, and calorie intake, we didn’t account for genetic factors and other variables that are either unknown or inadequately measured. Due to the cross-sectional design of our study, establishing causal relationships is challenging. The use of a semiquantitative dietary assessment questionnaire also poses the risk of recall bias given its subjective nature. Nonetheless, a strength of this research is the examination of a comprehensive range of variables.
Conclusions
In our cross-sectional study of overweight and obese Iranians, an increase in dietary BCAA was significantly associated with an increase in weight (P = 0.005), BMI (P = 0.007), WC (P = 0.002), WHR (P = 0.017), and FFM (P = 0.035) and a decrease in FM % (P = 0.005) and FM (P = 0.038). In addition, increased intake of BCAAs significantly decreased blood LDL levels (P = 0.027).
Acknowledgements
We thank all of the study participants. We are also thankful to the Research Undersecretary of Tabriz University of Medical Sciences for their financial support (Grant number: 72940).
Abbreviations
- FFQ
Food frequency questionnaire
- PA
Physical activity
- BMI
Body mass index
- ANOVA
Analysis of variance
- ANCOVA
Analysis of covariance
- BIA
Bioelectric impedance analysis
- MAC
Mid arm circumference
- MFP
Meat Fish Poultry
- WC
Waist circumference
- WHR
Waist to hip ratio
- FFA
Free fatty acids
- BCAA
Branched-chain amino acids
- TC
Total cholesterol
- LDL
Low-density lipoprotein
- HDL
High-density lipoprotein
- TG
Triglyceride
- WHO
World Health Organization
- HC
Hip circumference
- IPAQ
International Physical Activity Questionnaire
- FBS
Fasting blood glucose
- FI
Fasting insulin
- SD
Standard deviation
- GLM
general linear model
- VAT
visceral adipose tissue
- BCKD
branched-chain alpha-keto acid dehydrogenase complex
- FM
Fat mass
- BMI
Body mass index
Authors’ contributions
All authors approved the final version of the article. MAF and FJ designed the project and supervised it. ES wrote the first draft of the manuscript and also contributed to statistical analysis. FR, FJ and BH were involved in hypothesis generation and the statistical approach. ASH, FJ and YS were involved in data collection, revision and subjects’ recruitment. MAF and FJ also were involved in revision.
Funding
The present study was financially supported by a grant from Tabriz University of Medical Sciences. (Code: IR.TBZMED.REC.1398.460). The funders had no role in hypothesis generation, recruiting, and designing the study. Their role was only financial support.
Data Availability
(ADM)
The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Declarations
Ethics approval and consent to participate
The study protocol received approval from the ethics committee of Tabriz University of Medical Sciences (Code: IR.TBZMED.REC.1398.460). All participants provided their written informed consent prior to their involvement in the study. Furthermore, all methods employed in this research adhered to the guidelines and regulations set by the Declaration of Helsinki.
Consent for publication
Not applicable.
Competing interests
None.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Oda E, Kawai R. Age-and gender-related differences in correlations between abdominal obesity and obesity-related metabolic risk factors in japanese. Intern Med. 2009;48(7):497–502. doi: 10.2169/internalmedicine.48.1765. [DOI] [PubMed] [Google Scholar]
- 2.Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Prospective studies collaboration: body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96. doi: 10.1016/S0140-6736(09)60318-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care. 2005;28(6):1463–71. doi: 10.2337/diacare.28.6.1463. [DOI] [PubMed] [Google Scholar]
- 4.Lakka H-M, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709–16. doi: 10.1001/jama.288.21.2709. [DOI] [PubMed] [Google Scholar]
- 5.Liu Y, Tong G, Tong W, Lu L, Qin X. Can body mass index, waist circumference, waist-hip ratio and waist-height ratio predict the presence of multiple metabolic risk factors in chinese subjects? BMC Public Health. 2011;11:35. doi: 10.1186/1471-2458-11-35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Shou J, Chen P-J, Xiao W-H. The Effects of BCAAs on insulin resistance in athletes. J Nutri Sci Vitaminol. 2019;65(5):383–9. doi: 10.3177/jnsv.65.383. [DOI] [PubMed] [Google Scholar]
- 7.Kawaguchi T, Izumi N, Charlton MR, Sata M. Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology. 2011;54(3):1063–70. doi: 10.1002/hep.24412. [DOI] [PubMed] [Google Scholar]
- 8.Lynch CJ, Adams SH. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Reviews Endocrinol. 2014;10(12):723–36. doi: 10.1038/nrendo.2014.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Blomstrand E, Eliasson J, Karlsson HK, Köhnke R. Branched-chain amino acids activate key enzymes in protein synthesis after physical exercise. J Nutr. 2006;136(1 Suppl):269s–73s. doi: 10.1093/jn/136.1.269S. [DOI] [PubMed] [Google Scholar]
- 10.Banerjee P, Kumar T, Sarangi SC, Meetei UD, Devi AS, Kumar R. Anti-inflammatory potential of aqueous extract of Elsoltzia stachyodes on experimental models of inflammation in rats. J Nat Sci Biology Med. 2021;12(1):104. [Google Scholar]
- 11.Badoud F, Lam KP, DiBattista A, Perreault M, Zulyniak MA, Cattrysse B, et al. Serum and adipose tissue amino acid homeostasis in the metabolically healthy obese. J Proteome Res. 2014;13(7):3455–66. doi: 10.1021/pr500416v. [DOI] [PubMed] [Google Scholar]
- 12.Würtz P, Soininen P, Kangas AJ, Rönnemaa T, Lehtimäki T, Kähönen M, et al. Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care. 2013;36(3):648–55. doi: 10.2337/dc12-0895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Yamakado M, Tanaka T, Nagao K, Ishizaka Y, Mitushima T, Tani M, et al. Plasma amino acid profile is associated with visceral fat accumulation in obese japanese subjects. Clin Obes. 2012;2(1–2):29–40. doi: 10.1111/j.1758-8111.2012.00039.x. [DOI] [PubMed] [Google Scholar]
- 14.Asoudeh F, Salari-Moghaddam A, Hassanzadeh Keshteli A, Esmaillzadeh A, Adibi P. Dietary intake of branched-chain amino acids in relation to general and abdominal obesity2021. [DOI] [PubMed]
- 15.Xu X, Li B, Wang W, Chen S, Zhou W, Xu X. Duration of nocinto combined with early cardiac rehabilitation on cardiopulmonary reserve function and prognostic health in patients with acute myocardial infarction with heart failure. Archives of Clinical Psychiatry. 2022;49(3).
- 16.Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, et al. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab. 2008;4(7):382–93. doi: 10.1038/ncpendmet0843. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34(6):1249–57. doi: 10.2337/dc11-0442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Miles L. Physical activity and health. Nutr Bull. 2007;32(4):314–63. doi: 10.1111/j.1467-3010.2007.00668.x. [DOI] [Google Scholar]
- 19.Im J, Park H, Park K. Higher intake of total dietary essential amino acids is Associated with a lower prevalence of metabolic syndrome among korean adults. Nutrients. 2022;14(22):4771. doi: 10.3390/nu14224771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Sucher S, Markova M, Hornemann S, Pivovarova O, Rudovich N, Thomann R, et al. Comparison of the effects of diets high in animal or plant protein on metabolic and cardiovascular markers in type 2 diabetes: a randomized clinical trial. Diabetes Obes Metab. 2017;19(7):944–52. doi: 10.1111/dom.12901. [DOI] [PubMed] [Google Scholar]
- 21.Kubacka J, Cembrowska P, Sypniewska G, Stefanska A. The Association between branched-chain amino acids (BCAAs) and cardiometabolic risk factors in Middle-Aged caucasian women stratified according to Glycemic Status. Nutrients. 2021;13(10):3307. doi: 10.3390/nu13103307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Bell CN, Robles B, Singleton CR, Thomas Tobin CS, Spears EC, Thorpe RJ., Jr Association between Proximity to Food sources and dietary behaviors in Black and White College Graduates. Am J Health Behav. 2022;46(5):515–27. doi: 10.5993/AJHB.46.5.3. [DOI] [PubMed] [Google Scholar]
- 23.Zelenović M, Kontro T, Dumitru RC, Aksovic N, Bjelica B, Alexe DI et al. Leisure-time physical activity and all-cause mortality: a systematic review. Revista de Psicología del Deporte. 2022;31(1).
- 24.Nie C, He T, Zhang W, Zhang G, Ma X. Branched chain amino acids: Beyond Nutrition Metabolism. Int J Mol Sci. 2018;19(4). [DOI] [PMC free article] [PubMed]
- 25.Shah SH, Crosslin DR, Haynes CS, Nelson S, Turer CB, Stevens RD, et al. Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia. 2012;55(2):321–30. doi: 10.1007/s00125-011-2356-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Hamaya R, Mora S, Lawler PR, Cook NR, Ridker PM, Buring JE, et al. Association of plasma branched-chain amino acid with biomarkers of inflammation and lipid metabolism in women. Circ Genom Precis Med. 2021;14(4):e003330. doi: 10.1161/CIRCGEN.121.003330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wang W, Jiang H, Zhang Z, Duan W, Han T, Sun C. Interaction between dietary branched-chain amino acids and genetic risk score on the risk of type 2 diabetes in chinese. Genes Nutr. 2021;16(1):4. doi: 10.1186/s12263-021-00684-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Nagata C, Nakamura K, Wada K, Tsuji M, Tamai Y, Kawachi T. Branched-chain amino acid intake and the risk of diabetes in a Japanese Community: the Takayama Study. Am J Epidemiol. 2013;178(8):1226–32. doi: 10.1093/aje/kwt112. [DOI] [PubMed] [Google Scholar]
- 29.Zhang Y, Guo K, LeBlanc RE, Loh D, Schwartz GJ, Yu YH. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes. 2007;56(6):1647–54. doi: 10.2337/db07-0123. [DOI] [PubMed] [Google Scholar]
- 30.Rao S, Anthony ML, Chowdhury N, Kathrotia R, Mishra M, Naithani M et al. Molecular characterization of lung carcinomas: a study on diagnostic, predictive, and prognostic markers using immunohistochemical analysis at a Tertiary Care Center in Uttarakhand, India. J Carcinog. 2021;20. [DOI] [PMC free article] [PubMed]
- 31.Parker N, Atrooshi D, Lévesque L, Jauregui E, Barquera S, Taylor, JLy, et al. Physical activity and anthropometric characteristics among Urban Youth in Mexico: a cross-sectional study. J Phys Activity Health. 2016;13(10):1063–9. doi: 10.1123/jpah.2015-0463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Al-Obaidi ZMJ, Mohammed HR, Al AAE. The employment of standard addition method for the UV spectrophotometric assay of diclofenac alkaline salts in variant pharmaceutical dosage forms. J Global Pharma Technol. 2018;10(11s):377–38. [Google Scholar]
- 33.Simonson M, Boirie Y, Guillet C. Protein, amino acids and obesity treatment. Reviews in Endocrine and Metabolic Disorders. 2020;21(3):341–53. doi: 10.1007/s11154-020-09574-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Leman MA, Claramita M, Rahayu GR. Predicting factors on modeling health behavior: a systematic review. Am J Health Behav. 2021;45(2):268–78. doi: 10.5993/AJHB.45.2.7. [DOI] [PubMed] [Google Scholar]
- 35.Baker K, Figueroa R. Motivation, attitudes, and diet quality among US parents and adolescents. Am J Health Behav. 2021;45(1):125–37. doi: 10.5993/AJHB.45.1.10. [DOI] [PubMed] [Google Scholar]
- 36.Maida A, Chan JSK, Sjøberg KA, Zota A, Schmoll D, Kiens B, et al. Repletion of branched chain amino acids reverses mTORC1 signaling but not improved metabolism during dietary protein dilution. Mol Metab. 2017;6(8):873–81. doi: 10.1016/j.molmet.2017.06.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Solon-Biet SM, McMahon AC, Ballard JW, Ruohonen K, Wu LE, Cogger VC, et al. The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice. Cell Metab. 2014;19(3):418–30. doi: 10.1016/j.cmet.2014.02.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Solon-Biet SM, Cogger VC, Pulpitel T, Wahl D, Clark X, Bagley EE, et al. Branched-chain amino acids impact health and lifespan indirectly via amino acid balance and appetite control. Nat Metabolism. 2019;1(5):532–45. doi: 10.1038/s42255-019-0059-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Cummings NE, Williams EM, Kasza I, Konon EN, Schaid MD, Schmidt BA, et al. Restoration of metabolic health by decreased consumption of branched-chain amino acids. J Physiol. 2018;596(4):623–45. doi: 10.1113/JP275075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Abbasalizad Farhangi M, Vajdi M, Nikniaz L, Nikniaz Z. Interaction between Vascular endothelial growth Factor-A (rs2010963) gene polymorphisms and dietary diversity score on Cardiovascular Risk factors in patients with metabolic syndrome. Lifestyle Genom. 2020;13(1):1–10. doi: 10.1159/000503789. [DOI] [PubMed] [Google Scholar]
- 41.Khodarahmi M, Asghari-Jafarabadi M, Abbasalizad Farhangi M. A structural equation modeling approach for the association of a healthy eating index with metabolic syndrome and cardio-metabolic risk factors among obese individuals. PLoS ONE. 2019;14(7):e0219193. doi: 10.1371/journal.pone.0219193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Soleimani E, Abbasalizad Farhangi M. Protein quality, glycemic and metabolic indices and anthropometric features among overweight and obese adults. Nutr Metab Insights. 2023;16:11786388231181038. doi: 10.1177/11786388231181038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Asghari G, Farhadnejad H, Teymoori F, Mirmiran P, Tohidi M, Azizi F. High dietary intake of branched-chain amino acids is associated with an increased risk of insulin resistance in adults. J Diabetes. 2018;10(5):357–64. doi: 10.1111/1753-0407.12639. [DOI] [PubMed] [Google Scholar]
- 44.Burke JF, Sussman JB, Kent DM, Hayward RA. Three simple rules to ensure reasonably credible subgroup analyses. BMJ. 2015;351. [DOI] [PMC free article] [PubMed]
- 45.Dijkman B, Kooistra B, Bhandari M. How to work with a subgroup analysis. Can J Surg. 2009;52(6):515. [PMC free article] [PubMed] [Google Scholar]
- 46.Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–62. doi: 10.1017/S1368980009991698. [DOI] [PubMed] [Google Scholar]
- 47.Esfahani FH, Asghari G, Mirmiran P, Azizi F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran lipid and glucose study. J Epidemiol. 2010;20(2):150–8. doi: 10.2188/jea.JE20090083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.FoodData Central takes the analysis, compilation, and presentation of nutrient and food component data to a new level. [Internet]. 2023 [cited Planned for October 2023]. Available from: https://fdc.nal.usda.gov/.
- 49.Kl M, Escott-Stump S, Jl R. Krause’s Food & the Nutrition Care Process2020.
- 50.Oh J-Y, YANG Y-J, KIM B-S, KANG J-H. Validity and reliability of korean version of International Physical Activity Questionnaire (IPAQ) short form. J Korean Acad Family Med. 2007:532–41.
- 51.Fukuyama N, Homma K, Wakana N, Kudo K, Suyama A, Ohazama H, et al. Validation of the Friedewald equation for evaluation of plasma LDL-cholesterol. J Clin Biochem Nutr. 2007;43(1):1–5. doi: 10.3164/jcbn.2008036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9. doi: 10.1007/BF00280883. [DOI] [PubMed] [Google Scholar]
- 53.Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402–10. doi: 10.1210/jcem.85.7.6661. [DOI] [PubMed] [Google Scholar]
- 54.Rietman A, Schwarz J, Tomé D, Kok FJ, Mensink M. High dietary protein intake, reducing or eliciting insulin resistance? Eur J Clin Nutr. 2014;68(9):973–9. doi: 10.1038/ejcn.2014.123. [DOI] [PubMed] [Google Scholar]
- 55.Newgard CB. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 2012;15(5):606–14. doi: 10.1016/j.cmet.2012.01.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Batch BC, Shah SH, Newgard CB, Turer CB, Haynes C, Bain JR, et al. Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. Metabolism. 2013;62(7):961–9. doi: 10.1016/j.metabol.2013.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Hamaya R, Mora S, Lawler PR, Cook NR, Ridker PM, Buring JE et al. Association of Plasma Branched-Chain Amino Acid With Biomarkers of Inflammation and Lipid Metabolism in Women. Circulation: Genomic and Precision Medicine. 2021;14(4):e003330. [DOI] [PMC free article] [PubMed]
- 58.Wang C, Guo F. Branched chain amino acids and metabolic regulation. Chin Sci Bull. 2013;58(11):1228–35. doi: 10.1007/s11434-013-5681-x. [DOI] [Google Scholar]
- 59.Qin LQ, Xun P, Bujnowski D, Daviglus ML, Van Horn L, Stamler J, et al. Higher branched-chain amino acid intake is associated with a lower prevalence of being overweight or obese in middle-aged east asian and western adults. J Nutr. 2011;141(2):249–54. doi: 10.3945/jn.110.128520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Saha S, Ghosh A, Acharyya S, Sarkar S. Fusion of tea infusion and Bakhar (starter of ethnic liquor Haria) to develop tea haria: a novel approach to ferment tea with insight into in vitro biochemical attributes and metabolomics. J Food Technol. 2022;9(1):1–17. [Google Scholar]
- 61.Zheng Y, Li Y, Qi Q, Hruby A, Manson JE, Willett WC, et al. Cumulative consumption of branched-chain amino acids and incidence of type 2 diabetes. Int J Epidemiol. 2016;45(5):1482–92. doi: 10.1093/ije/dyw143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Holeček M. Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements. Nutr Metabolism. 2018;15(1):33. doi: 10.1186/s12986-018-0271-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Bifari F, Nisoli E. Branched-chain amino acids differently modulate catabolic and anabolic states in mammals: a pharmacological point of view. Br J Pharmacol. 2017;174(11):1366–77. doi: 10.1111/bph.13624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Yoon MS. The emerging role of branched-chain amino acids in insulin resistance and metabolism. Nutrients. 2016;8(7). [DOI] [PMC free article] [PubMed]
- 65.Ye Z, Wang S, Zhang C, Zhao Y. Coordinated modulation of Energy metabolism and inflammation by branched-chain amino acids and fatty acids. Front Endocrinol. 2020;11. [DOI] [PMC free article] [PubMed]
- 66.Yang P, Hu W, Fu Z, Sun L, Zhou Y, Gong Y, et al. The positive association of branched-chain amino acids and metabolic dyslipidemia in chinese Han population. Lipids Health Dis. 2016;15:120. doi: 10.1186/s12944-016-0291-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Herman MA, She P, Peroni OD, Lynch CJ, Kahn BB. Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA Levels*. J Biol Chem. 2010;285(15):11348–56. doi: 10.1074/jbc.M109.075184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Cheng S, Wiklund P, Autio R, Borra R, Ojanen X, Xu L, et al. Adipose tissue dysfunction and altered systemic amino acid metabolism are Associated with non-alcoholic fatty liver disease. PLoS ONE. 2015;10(10):e0138889. doi: 10.1371/journal.pone.0138889. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Ribeiro RV, Solon-Biet SM, Pulpitel T, Senior AM, Cogger VC, Clark X et al. Of older mice and men: branched-chain amino acids and body composition. Nutrients. 2019;11(8). [DOI] [PMC free article] [PubMed]
- 70.Green CR, Wallace M, Divakaruni AS, Phillips SA, Murphy AN, Ciaraldi TP, et al. Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis. Nat Chem Biol. 2016;12(1):15–21. doi: 10.1038/nchembio.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Rietman A, Stanley TL, Clish C, Mootha V, Mensink M, Grinspoon SK, et al. Associations between plasma branched-chain amino acids, β-aminoisobutyric acid and body composition. J Nutr Sci. 2016;5:e6. doi: 10.1017/jns.2015.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Lackey DE, Lynch CJ, Olson KC, Mostaedi R, Ali M, Smith WH, et al. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am J Physiol Endocrinol Metab. 2013;304(11):E1175–87. doi: 10.1152/ajpendo.00630.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9(4):311–26. doi: 10.1016/j.cmet.2009.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
(ADM)
The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.